Genomic evolution from primary breast carcinoma to distant metastasis: Few copy number changes of breast cancer related genes.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cancer Letters

• Publication date

  2014-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2013.10.025PMID 24184827
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas

  2013cited by this paper
• SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization.

  2013cited by this paper
• FGFR1 is amplified during the progression of in situ to invasive breast carcinoma

  2012cited by this paper
• Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases

  2012cited by this paper
• Molecular insights on basal-like breast cancer

  2012cited by this paper
• Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells.

  2012cited by this paper
• Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer

  2012cited by this paper
• Relevance of PTEN loss in brain metastasis formation in breast cancer patients

  2012cited by this paper
• Erratum: Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: A multiplex ligation-dependent probe amplification study (Analytical Cellular Pathology (2010) 33:3-4 (165-173))

  2011cited by this paper
• Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study

  2011cited by this paper
• Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers

  2011cited by this paper
• Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts

  2011cited by this paper
• The role of Tau protein in resistance to paclitaxel

  2011cited by this paper
• Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients

  2011cited by this paper
• ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study

  2011cited by this paper
• Astrocyte elevated gene-1 and breast cancer (Review).

  2011cited by this paper
• Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study

  2011cited by this paper
• The Genomic Relationship Between Primary Breast Carcinomas and Their Nodal Metastases

  2011cited by this paper
• Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft

  2010cited by this paper
• FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.

  2010cited by this paper
• Metastatic behavior of breast cancer subtypes.

  2010cited by this paper
• Receptor conversion in distant breast cancer metastases

  2010cited by this paper
• Multiplex Ligation-Dependent Probe Amplification to Detect HER2 Amplification in Breast Cancer: New Insights in Optimal Cut-Off Value

  2010cited by this paper
• Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes

  2010cited by this paper
• Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells

  2010cited by this paper
• Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression

  2010cited by this paper
• Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer

  2009cited by this paper
• HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection

  2009cited by this paper
• Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.

  2009cited by this paper
• MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer.

  2009cited by this paper
• HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization

  2008cited by this paper
• Breast cancer metastases are molecularly distinct from their primary tumors

  2008cited by this paper
• TRAF4 overexpression is a common characteristic of human carcinomas

  2007cited by this paper
• Gene amplification and overexpression of PRDM14 in breast cancers.

  2007cited by this paper
• Evaluating distant metastases in breast cancer: from biology to outcomes

  2007cited by this paper
• Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node–Negative Breast Cancer Patients

  2006cited by this paper
• Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients.

  2006cited by this paper
• Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

  2005cited by this paper
• Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer

  2005cited by this paper
• Genes that mediate breast cancer metastasis to lung

  2005cited by this paper
• A multigenic program mediating breast cancer metastasis to bone.

  2003cited by this paper
• Gene expression profiles of primary breast tumors maintained in distant metastases

  2003cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• No consent should be needed for using leftover body material for scientific purposes. For.

  2002cited by this paper
• Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

  2002cited by this paper
• No consent should be needed for using leftover body material for scientific purposes. Against.

  2002cited by this paper
• Genetic alterations in primary breast cancers and their metastases: Direct comparison using modified comparative genomic hybridization

  1997cited by this paper
• Metastasizing potentials of mouse mammary tumors and their metastases

  1988cited by this paper
• Spontaneous and induced metastasis of naturally occurring tumors in mice: analysis of cell shedding into the blood.

  1984cited by this paper
• Biological diversity in metastatic neoplasms: origins and implications.

  1982cited by this paper
• Metastasizing capacity of tumour cells from spontaneous metastases of transplanted murine tumours.

  1980cited by this paper
• The pathogenesis of cancer metastasis

  1980cited by this paper
• Metastasis results from preexisting variant cells within a malignant tumor.

  1977cited by this paper

• Functional and molecular single-cell analyses implicate PRDM14 in the initiation of B cell leukemia in mice

  2025cites this paper
• AEG-1 on cancer drug resistance: From molecular insights to therapeutic challenges.

  2025cites this paper
• Molecular alterations and prognosis of breast cancer with cutaneous metastasis

  2024cites this paper
• Chromatin Remodeling Enzyme Cluster Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Breast Cancer

  2023cites this paper
• The Research Progress in Physiological and Pathological Functions of TRAF4

  2022cites this paper
• HOXA1, a breast cancer oncogene.

  2022cites this paper
• Beyond Genetics: Metastasis as an Adaptive Response in Breast Cancer

  2022cites this paper
• Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis

  2021cites this paper
• Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer

  2020cites this paper
• Multifaceted Role of PRDM Proteins in Human Cancer

  2020cites this paper
• High expression of TRAF4 predicts poor prognosis in tamoxifen-treated breast cancer and promotes tamoxifen resistance

  2020cites this paper
• Concordance of Genomic Alterations between Circulating Tumor DNA and Matched Tumor Tissue in Chinese Patients with Breast Cancer

  2020cites this paper
• MTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy.

  2019cites this paper
• Screening of the copy number increase of AKT in lung carcinoma by custom-designed MLPA.

  2019cites this paper
• Off to a Bad Start: Cancer Initiation by Pluripotency Regulator PRDM14.

  2019cites this paper
• Analysis of gene copy number changes in head and neck cancer

  2018cites this paper
• Mutation Profiling of Key Cancer Genes in Primary Breast Cancers and Their Distant Metastases.

  2018cites this paper
• High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer

  2018cites this paper
• Identification of mechanisms of acquired resistance to taxanes in triple negative breast cancer using patient-derived xenografts: a step closer to clinics

  2018cites this paper
• Detection of CCND1 Gene Copy Number Variations Using Multiplex Ligation-Dependent Probe Amplification and Fluorescence In Situ Hybridization Methods.

  2018cites this paper
• Glucose insult elicits hyperactivation of cancer stem cells through miR-424–cdc42–prdm14 signalling axis

  2017cites this paper
• TAF2: A potential oncogene for hepatocellular carcinoma

  2017cites this paper
• Positively Selected Enhancer Elements Endow Tumor Cells with Metastatic Competence

  2017cites this paper
• Positively selected enhancer elements endow osteosarcoma cells with metastatic competence

  2017cites this paper
• Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.

  2017cites this paper
• AEG-1/MTDH/LYRIC: A Promiscuous Protein Partner Critical in Cancer, Obesity, and CNS Diseases.

  2016cites this paper
• Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases

  2016cites this paper
• Catalog of genetic progression of human cancers: breast cancer

  2016cites this paper
• Comparison of Predictive Immunohistochemical Marker Expression of Primary Breast Cancer and Paired Distant Metastasis using Surgical Material

  2016cites this paper
• Screening for the optimal gene and functional gene sets related to breast cancer using differential co-expression and differential expression analysis

  2016cites this paper
• Molecular Concordance Between Primary Breast Cancer and Matched Metastases

  2016cites this paper
• Survival of breast cancer patients according to changes in expression of selected markers between primary tumor and lymph node metastases.

  2016cites this paper
• The genomic landscape of breast cancer and its interaction with host immunity.

  2016cites this paper
• Alteraciones moleculares de la señalización estrogénica en el Cáncer de Mama con receptores hormonales positivos

  2016cites this paper
• Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis

  2015cites this paper
• Focused analysis of genomic alterations in primary breast carcinomas and corresponding metastases

  2015cites this paper
• Screening for candidate genes related to breast cancer with cDNA microarray analysis

  2015cites this paper
• Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics

  2015cites this paper
• Lymphovascular invasion and histologic grade are associated with specific genomic profiles in invasive carcinomas of the breast

  2014influential citation
• MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway

  2014cites this paper
• AEG-1/MTDH/LYRIC: clinical significance.

  2013cites this paper